
An experimental vaccine against the coronavirus showed encouraging results in very early testing, triggering hoped-for immune responses in eight healthy, middle-aged volunteers, its maker announced Monday.
from CBC | Health News https://ift.tt/3bFzJ2H
Aucun commentaire:
Enregistrer un commentaire